Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ruby M. van Stein"'
Autor:
Ruby M. van Stein, Florine J. Hendriks, Valesca P. Retèl, Cor D. de Kroon, Christianne A.R. Lok, Gabe S. Sonke, Kelly M. de Ligt, Willemien J. van Driel
Publikováno v:
Gynecologic Oncology Reports, Vol 50, Iss , Pp 101293- (2023)
Purpose: Measuring health-related quality of life (HRQoL) in ovarian cancer patients is critical to understand the impact of disease and treatment. Preference-based HRQoL measures, called health state utilities, are used specifically in health econom
Externí odkaz:
https://doaj.org/article/b5cf6e67f45f4faf825b7fef5a01c0df
Autor:
Ruby M. van Stein, Christianne A.R. Lok, Arend G.J. Aalbers, Ignace H.J.T. de Hingh, Aletta P.I. Houwink, Herman J. Stoevelaar, Gabe S. Sonke, Willemien J. van Driel
Publikováno v:
Gynecologic Oncology Reports, Vol 39, Iss , Pp 100945- (2022)
Objective: Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is standard of care in the Netherlands in patients with stage III epithelial ovarian cancer following interval cytoreductive surgery (CRS). Differences in patient selection, technical aspec
Externí odkaz:
https://doaj.org/article/35e6fa26bd3f4cf4b5fbe535a21ed622
Autor:
Daniel J. C. Berkhout, Marc A. Benninga, Ruby M. van Stein, Paul Brinkman, Hendrik J. Niemarkt, Nanne K. H. de Boer, Tim G. J. de Meij
Publikováno v:
Sensors, Vol 16, Iss 11, p 1967 (2016)
Prior to implementation of volatile organic compound (VOC) analysis in clinical practice, substantial challenges, including methodological, biological and analytical difficulties are faced. The aim of this study was to evaluate the influence of sever
Externí odkaz:
https://doaj.org/article/a651296062434970b7d7fdb693136ec7
Publikováno v:
BJOG: An International Journal of Obstetrics & Gynaecology. 130:135-140
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d11e8b62173038e021c9e0297f541922
https://doi.org/10.1111/1471-0528.17289
https://doi.org/10.1111/1471-0528.17289
Autor:
Ruby M, van Stein, Karolina, Sikorska, Maaike A, van der Aa, Gabe S, Sonke, Willemien J, van Driel
Publikováno v:
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and ObstetricsREFERENCES.
The OVHIPEC-1 trial (Phase III randomised clinical trial for stage III ovarian carcinoma randomising between interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy) showed improved survival when interval cytoreductiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20a5b4da21879dbc3bdcf42482d095e2
https://pubmed.ncbi.nlm.nih.gov/36495280
https://pubmed.ncbi.nlm.nih.gov/36495280
Publikováno v:
Journal of gynecologic oncology. 33(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3faafe2a42316d496c87adda7468e36
https://pubmed.ncbi.nlm.nih.gov/35712968
https://pubmed.ncbi.nlm.nih.gov/35712968
Publikováno v:
JAMA oncology. 7(8)
Importance The peritoneal surface is a common site of disease in ovarian and colorectal cancer. Peritoneal metastases carry a poor prognosis, despite maximal therapeutic efforts, including surgical removal of tumor deposits and intravenous chemothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8e4f894c929e5a5e83e964465cb0e87
https://pubmed.ncbi.nlm.nih.gov/33956063
https://pubmed.ncbi.nlm.nih.gov/33956063
Autor:
Ruby M. van Stein, Maurits Engbersen, Tessa Stolk, Christianne A. R. Lok, Max J. Lahaye, Gabe S. Sonke, Willemien J. van Driel
Publikováno v:
Gynecologic Oncology. 162:S243-S244
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2216de04f44626481ddb6b963902e9d4
https://doi.org/10.1016/s0090-8258(21)01113-6
https://doi.org/10.1016/s0090-8258(21)01113-6
Autor:
Pierre-Emmanuel Colombo, Ruby M. van Stein, Willemien J. van Driel, Karolina Sikorska, Donal J. Brennan, Gabe S. Sonke, Simone N. Koole, Valesca P. Retèl, Desmond P.J. Barton, Oliver Zivanovic, Berit Jul Mosgaard, Lewis Perrin, Anna Fagotti
Publikováno v:
Journal of Clinical Oncology. 38:TPS6100-TPS6100
TPS6100 Background: The addition of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to interval cytoreductive surgery improves recurrence-free and overall survival in patients with FIGO stage III ovarian cancer who are ineligible for primary cytore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34684d007cec77e7fd9f9e207d40c1c2
https://doi.org/10.1200/jco.2020.38.15_suppl.tps6100
https://doi.org/10.1200/jco.2020.38.15_suppl.tps6100